Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
pcsk9 inhibitors long term side effects | 0.41 | 0.1 | 5733 | 86 | 39 |
pcsk9 | 1.46 | 0.8 | 6257 | 33 | 5 |
inhibitors | 0.85 | 0.7 | 6121 | 24 | 10 |
long | 0.04 | 0.5 | 3629 | 29 | 4 |
term | 1.83 | 0.2 | 1628 | 97 | 4 |
side | 0.74 | 0.7 | 178 | 2 | 4 |
effects | 1.71 | 0.7 | 6680 | 23 | 7 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
pcsk9 inhibitors long term side effects | 1.96 | 0.6 | 6867 | 4 |
pcsk9 inhibitors side effects discussion | 1.41 | 0.2 | 6688 | 17 |
dangers of pcsk9 inhibitors | 0.28 | 0.4 | 1991 | 26 |
what is the downside of pcsk9 inhibitors | 1.31 | 0.6 | 4904 | 67 |
pcsk 9 side effects | 1.77 | 0.6 | 9132 | 94 |
pcsk9 inhibitors patient information | 1.56 | 0.2 | 8569 | 34 |
pcsk9 inhibitors cardiovascular outcomes | 0.75 | 0.2 | 1730 | 8 |
pcsk9 inhibitors and mortality benefit | 0.03 | 0.1 | 4370 | 54 |
what are the risks of taking pcsk9s | 0.62 | 0.5 | 5330 | 95 |
indications for pcsk9 inhibitor | 0.39 | 0.3 | 1839 | 14 |
pcsk 9 inhibitors uk patient informaion | 1.13 | 0.8 | 2906 | 55 |
are pcsk9 inhibitors safe | 1.83 | 0.1 | 6135 | 62 |
pcsk9 inhibitors and lp a | 1.65 | 0.9 | 8099 | 34 |
pcsk9 inhibitors twice a year | 0.33 | 0.3 | 1394 | 64 |
pcsk9 inhibitors and liver disease | 0.73 | 0.3 | 5111 | 10 |
pcsk9 inhibitor guideline update | 1.15 | 0.9 | 3952 | 72 |
contraindications to pcsk9 inhibitor | 1.24 | 0.1 | 9358 | 13 |